D4A0X3 AF NFT

AP2-interacting clathrin-endocytosis protein

MOLNFT AF v1 smart contract in GenesisL1 blockchain: 
0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD
IPFS of NFT metadata: 
bafybeid2zilnz5mfxac2iysnznxzshncb2hbsgslldhboy7c7rmgbogmpm/metadata.json
IPFS of structure file: 
bafybeic3qiqumj6q3t6s7eh2evtqmnbu3f575mbll6giwxr2edvmoruire/AF-D4A0X3-F1-model_v2.pdb
First NFT owner address (eip-55): 
0x29f928A539587e32C04DF7AaE14EcA8425395917
First NFT owner address (bech32): 
genesis198uj3ffetplr9szd774wznk2ssjnjkghhuftmg
Current NFT ID #196662 owner (web3):

First owner GALLERY | EVM EXPLORER | COSMOS EXPLORER

MOLNFT AF v1

NFT id:
196662
Accession (UniProt):
D4A0X3
Name::
AP2-interacting clathrin-endocytosis protein
Experimental Method:
Predicted structure
Sequence source:
RATTUS NORVEGICUS

NFT data

MolNFT AF v1 is an AlphaFold database of AI predicted Swiss-Prot protein sequences preserved as regular ERC-721 NFT tokens on GenesisL1 blockchain for public free use, research and entertainment:

https://alphafold.ebi.ac.uk/
Jumper, J., Evans, R., Pritzel, A. et al. Highly accurate protein structure prediction with AlphaFold. 
Nature 596, 583–589 (2021). https://doi.org/10.1038/s41586-021-03819-2

MOLNFT D4A0X3 research and analysis (ICN3D with VR)

FASTA sequences

>sp|D4A0X3|K1107_RAT AP2-interacting clathrin-endocytosis protein OS=Rattus norvegicus OX=10116 GN=Kiaa1107 PE=1 SV=3 MHIDDQQKIQAAALDKGDDRRLGRKPVLSSSQQRRQGSDVIKIKPWTGNNKKLCRASPSTNEKMRSDGLGASGHASGTHRNSVNKVSKHGEGTKVSKVTTEVKTGATHVPGKPKTTIKPQTENNAHTKLESISSTVVGRPARMAATGRKDLAHGKGIQNQEGETTGARPKVLTANLNTQARAKPLQTVKGKDNGCSATVGPSSRSANSSMERLASTGSVDETKENGSVEDKSCDKKPYVSASPGQMVYNGVTSTVAVKSRPVSRVTSGTSSKKSFIHEQGPSVTSSVIKKGRGSSKGLNDSAPQTAAKRGGSSNGYAAAQPRTKSAPPTLAQTQGSQGESPHSVKSSISSRQSDESVTRLRHGTDKQMPKRKVVKQGHATLQKVNAKPTPKNPSQSTKGGTMTSKDSKQKVLPGQVTLQSQASQRPSNPEAATTQRSVLHGVNDNRSQVFKQRPPESLVNLASDTNGPEASPSPCRPQPQSPLGNQEKTRQEREHQDGSTLGDSVKHELRSELTSIEQSHTPAYKVSSQCSANPNCGCIASLKPVTSNPSENWINSNTANTDQVCVSDRERQTGRKGTDREPSVNCVARKAALPSVPAGMSGTLKSAQDDRKLPFHREELSAQGHLPHDCATEDSKCATPTSAVSSRCLLGQPSEKGYKNMEASGTSESHEAPEAPFMGPWDLNTSATHQRESPESDTGSATTSSDDIKPRSEDYDAGGSQDDEGSHDRGVSKCSTALCHDFLGRSSSDTSTPEELKVHEGDLRTEVRVRKPGGGDLPLHSASDDETPRKKPDPWSRSTIVHPREKGSAPRGSVPSAQEVDQVSSSADETEDERSEAENVREHSSPSNSGTQHVQGIINLAFEDGTEHESREFSATKKFRRSVLLSVDECEEVGSDEGEGHTPLQPSLDSLSPSDVFDGVSYEHHGRTGYSRFFKENEATTAEHKYSRGNDGHKNEGFLLSPRSRDFPRQGKQCVSTGEKTRLDVPPKASQQPFPESKDMTSKREVAHGLQQHGTLTDGDTRSQERPCHLELHQREPSSTIPKISSARSLDSCPSQVLPQDGQVTATHPTPPKRANNAVFSGDIDDCDTMAQTTMYDHRPSKTLSPIHEMSLTAACEQKEESGTHVADRASEDEQPFAKQDWTLLKQLLSEQDANLNVTSSLPEDLSLAQYLINQTLLLARDSSKPQGSAHADTWNRWSELSSPLDDLTASATTVSVSSTDCSPQGEWTILELETQH